Physician

Greg James Mott, M.D.

According to 2025 Medicare claims, Greg Mott, M.D. (NPI: 1093101750) practices rheumatology in the Dayton-Kettering-Beavercreek, OH market, with the plurality of this provider's patient population coming from Montgomery, OH. This provider's primary affiliated billing organization is DAYTON ARTHRITIS AND ALLERGY CENTER LLC (NPI: 1912087511; TIN: 311811998) and primary practice location at 45409-1332.

Mott's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 277 traditional Medicare patients, billed 46,757 HCPCS/CPT codes, and received $735,767 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,763 prescription claims across 326 beneficiaries totaling $1,529,212 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 32 records totaling $555. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $59,680 to $735,767. Similarly, Part D prescription costs have risen steadily, from $1,027 to $1,529,212. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$368K$736K2020 Medicare payment: $59,680 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $287,843 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $523,393 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $535,374 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $735,767 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020952,082$59,680
20212457,257$287,843
202228317,161$523,393
202327332,213$535,374
202427746,757$735,767

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$765K$1.5M2015 Drug cost: $1,027 (USD; Tot_Drug_Cst)2016 Drug cost: $21,901 (USD; Tot_Drug_Cst)2017 Drug cost: $71,128 (USD; Tot_Drug_Cst)2018 Drug cost: $192,846 (USD; Tot_Drug_Cst)2019 Drug cost: $457,691 (USD; Tot_Drug_Cst)2020 Drug cost: $73,700 (USD; Tot_Drug_Cst)2021 Drug cost: $390,655 (USD; Tot_Drug_Cst)2022 Drug cost: $1,038,777 (USD; Tot_Drug_Cst)2023 Drug cost: $1,278,580 (USD; Tot_Drug_Cst)2024 Drug cost: $1,529,212 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151120$1,027
201677279$21,901
2017931,473$71,128
2018113492$192,846
201960593$457,691
202098337$73,700
20212281,490$390,655
20222861,904$1,038,777
20232941,691$1,278,580
20243261,763$1,529,212

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more8383$109
96413Administration of chemotherapy into vein, 1 hour or less39174$90
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more109214$84
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more140192$58
96372Injection of drug or substance under skin or into muscle4057$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept501,596$431,825
Humira(Cf) PenAdalimumab471,372$421,376
Orencia ClickjectAbatacept291,262$267,932
RinvoqUpadacitinib12420$88,313
OtezlaApremilast12360$67,882

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.32$555ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Greg James Mott, M.D.?

Tedicare shows public-source Medicare data for Greg James Mott, M.D. (NPI 1093101750), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Greg James Mott, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Greg James Mott, M.D.?

Greg James Mott, M.D. is linked to DAYTON ARTHRITIS AND ALLERGY CENTER LLC (billing NPI 1912087511) in the available physician profile data.

Does Greg James Mott, M.D. have Open Payments data?

Greg James Mott, M.D. has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.